Pyrotinib Maleate Combined With Vinorelbine in the Treatment of HER2-positive Advanced Breast Cancer

NCT04903652 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

HER2-positive Advanced Breast Cancer

Interventions

DRUG: Pyrotinib Maleate
DRUG: Vinorelbine

Sponsor

Tianjin Medical University Cancer Institute and Hospital